Pages that link to "Q33875688"

The following pages link to Management of the frail person with advanced cancer (Q33875688):

Displaying 30 items.

• Bladder cancer in the elderly patient: challenges and solutions (Q28082782) (← links)
• Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial (Q33407102) (← links)
• Frailty and inflammatory markers in older adults with cancer (Q33563551) (← links)
• Geriatric oncology: challenges for the new century (Q34023948) (← links)
• Cancer and age in the USA. (Q34134684) (← links)
• Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: correlation with chronological age but not with fitness/frailty status (Q34380210) (← links)
• Management of breast cancer in the older woman (Q34386713) (← links)
• Epidemiology of breast cancer in older women: implications for future healthcare (Q34458444) (← links)
• Importance of a comprehensive geriatric assessment in older cancer patients. (Q34558195) (← links)
• A case for geriatric oncology (Q34688646) (← links)
• Management of complications of androgen deprivation therapy in the older man. (Q34782101) (← links)
• Association of Cancer With Geriatric Syndromes in Older Medicare Beneficiaries (Q34866406) (← links)
• Colorectal cancer in the elderly: is palliative chemotherapy of value? (Q35039124) (← links)
• TREATMENT AND SURVIVAL PATTERNS IN RELATION TO MULTIMORBIDITY IN PATIENTS WITH LOCOREGIONAL BREAST AND COLORECTAL CANCER (Q35117528) (← links)
• Assessment and interpretation of comorbidity burden in older adults with cancer (Q35419280) (← links)
• Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions (Q35709872) (← links)
• Biological ageing and frailty markers in breast cancer patients (Q35744970) (← links)
• Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA. (Q35989968) (← links)
• Oral versus intravenous vinorelbine: clinical safety profile. (Q36235526) (← links)
• Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients (Q36299985) (← links)
• A Scoping Review of Frailty and Acute Care in Middle-Aged and Older Individuals with Recommendations for Future Research (Q36342672) (← links)
• The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters (Q37327398) (← links)
• Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries (Q37608744) (← links)
• Individualized Decision-Making for Older Men With Prostate Cancer: Balancing Cancer Control With Treatment Consequences Across the Clinical Spectrum (Q37855234) (← links)
• Optimal management of renal cell carcinoma in the elderly: a review (Q38102680) (← links)
• The prevalence and correlates of fatigue in older cancer patients. (Q43769467) (← links)
• Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi (Q43782234) (← links)
• Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy (Q57801328) (← links)
• Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational study (Q64245528) (← links)
• A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation (Q79548601) (← links)